Herpes Zoster

12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections, Virus Diseases

Treatments and conditions

Herpes Zoster
Treatment and conditionWhere it standsTrials
Amezosvatein Adjuvant Dose Arm D for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm F for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm H for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm J for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm L for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen High Dose Arm A for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen Low Dose Arm B for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CVI-VZV-001 for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
dexmedetomidine nasal spray group + long duration high voltage pulse RF therapy group for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-dose experimental vaccine for herpes zosterPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Low-dose experimental vaccine for herpes zosterPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for herpes zosterPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.